Bioceres Crop Solutions Q3 2024 GAAP EPS $0.15 Misses $0.16 Estimate, Sales $84.000M Miss $98.500M Estimate
Portfolio Pulse from Benzinga Newsdesk
Bioceres Crop Solutions (NASDAQ:BIOX) reported Q3 2024 earnings of $0.15 per share, missing the $0.16 estimate, and sales of $84M, below the $98.5M estimate. This represents a significant decrease in both earnings and sales from the same period last year.
May 13, 2024 | 10:16 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bioceres Crop Solutions reported lower than expected Q3 2024 earnings and sales, missing analyst estimates. This reflects a significant year-over-year decline in performance.
Missing both earnings and sales estimates can lead to negative investor sentiment and potentially lower stock prices in the short term. The significant year-over-year decline in earnings and sales further compounds the negative outlook, suggesting operational or market challenges.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100